CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,123,947 | +25.6% | 372,146 | +82.9% | 0.01% | +42.9% |
| Q2 2023 | $6,467,644 | +46.3% | 203,449 | +12.3% | 0.01% | +40.0% |
| Q1 2023 | $4,420,029 | -24.5% | 181,223 | -2.3% | 0.01% | -28.6% |
| Q4 2022 | $5,852,058 | +13.2% | 185,544 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $5,171,000 | +6.9% | 185,544 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $4,839,000 | -29.4% | 183,008 | -6.5% | 0.01% | 0.0% |
| Q1 2022 | $6,855,000 | -2.2% | 195,808 | -9.4% | 0.01% | 0.0% |
| Q4 2021 | $7,006,000 | +36.1% | 216,108 | +23.9% | 0.01% | +20.0% |
| Q3 2021 | $5,147,000 | +35.1% | 174,476 | +12.9% | 0.01% | +25.0% |
| Q2 2021 | $3,809,000 | +141.8% | 154,590 | +34.8% | 0.00% | +100.0% |
| Q1 2021 | $1,575,000 | +155.7% | 114,715 | +208.7% | 0.00% | +100.0% |
| Q4 2020 | $616,000 | – | 37,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |